Skip to content
FORSIDEN
Log ind Opret konto
  • Kategorier
  • Seneste
  • Etiketter
  • Populære
  • Verden
  • Bruger
  • Grupper
Temaer
  • Light
  • Brite
  • Cerulean
  • Cosmo
  • Flatly
  • Journal
  • Litera
  • Lumen
  • Lux
  • Materia
  • Minty
  • Morph
  • Pulse
  • Sandstone
  • Simplex
  • Sketchy
  • Spacelab
  • United
  • Yeti
  • Zephyr
  • Dark
  • Cyborg
  • Darkly
  • Quartz
  • Slate
  • Solar
  • Superhero
  • Vapor

  • Default (No Skin)
  • No Skin
Kollaps
  1. Debatforum
  2. Kategorier
  3. Biotek-snakken
  4. Biotek-snakken — Maj 2024

Biotek-snakken — Maj 2024

Planlagt Fastgjort Låst Flyttet Biotek-snakken
67 Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • F Offline
    F Offline
    Fandel
    wrote on sidst redigeret af
    #29

    Godmorgen...

    1 Reply Last reply
    0
    • P Offline
      P Offline
      ProinvestorNEWS
      wrote on sidst redigeret af
      #30

      Photocure : Asieris' NDA For Cevira Accepted By NMPA For Regulatory Review In China https://www.proinvestor.com/investornyt/1158788/photocure-asieris-nda-for-cevira-accepted-by-nmpa-for-regulatory-review-in-china

      1 Reply Last reply
      0
      • L Offline
        L Offline
        LP90
        wrote on sidst redigeret af
        #31

        God nyhed med Photocure når man nu har lidt for mange af dem også 🙂

        1 Reply Last reply
        0
        • F Offline
          F Offline
          Fandel
          wrote on sidst redigeret af
          #32

          Godmorgen...

          1 Reply Last reply
          0
          • L Offline
            L Offline
            LP90
            wrote on sidst redigeret af
            #33

            Godmorgen 🙂

            1 Reply Last reply
            0
            • exitnuE Offline
              exitnuE Offline
              exitnu
              wrote on sidst redigeret af
              #34

              Calliditas’ Partner Everest Medicines Starts Commercial Launch of Nefecon in China

              Link Preview Image
              Calliditas Therapeutics AB

              Calliditas is a commercial stage biopharmaceutical company focused on identifying, developing and commercializing novel treatments in orphan indications, with an initial focus on renal and hepatic diseases with significant unmet medical needs.

              favicon

              Calliditas Therapeutics AB (www.calliditas.se)

              1 Reply Last reply
              0
              • exitnuE Offline
                exitnuE Offline
                exitnu
                wrote on sidst redigeret af
                #35

                “This is a fantastic result from many years of dedication and hard work by teams from both companies and I am delighted that patients in China now can benefit from Nefecon, which has been specifically designed to address the origin of IgAN,” said Renee Aguiar-Lucander, CEO.

                1 Reply Last reply
                0
                • F Offline
                  F Offline
                  Fandel
                  wrote on sidst redigeret af
                  #36

                  Godmorgen...

                  1 Reply Last reply
                  0
                  • L Offline
                    L Offline
                    LP90
                    wrote on sidst redigeret af
                    #37

                    Morning 🙂

                    1 Reply Last reply
                    0
                    • exitnuE Offline
                      exitnuE Offline
                      exitnu
                      wrote on sidst redigeret af
                      #38

                      Genovis - Interim Report January – March 2024

                      https://mb.cision.com/Main/1712/3976051/2798815.pdf

                      "Best quarter for enzyme business in analytics and stronger cash position"

                      1 Reply Last reply
                      0
                      • F Offline
                        F Offline
                        Fandel
                        wrote on sidst redigeret af
                        #39

                        Godmorgen...

                        1 Reply Last reply
                        0
                        • L Offline
                          L Offline
                          LP90
                          wrote on sidst redigeret af
                          #40

                          Morning 🙂

                          1 Reply Last reply
                          0
                          • F Offline
                            F Offline
                            Fandel
                            wrote on sidst redigeret af
                            #41

                            Godmorgen...

                            1 Reply Last reply
                            0
                            • L Offline
                              L Offline
                              LP90
                              wrote on sidst redigeret af
                              #42

                              Godmorgen 🙂

                              1 Reply Last reply
                              0
                              • D Offline
                                D Offline
                                DECIDE
                                wrote on sidst redigeret af
                                #43

                                Nanexa ser interessant ud.

                                1 Reply Last reply
                                0
                                • D Offline
                                  D Offline
                                  DECIDE
                                  wrote on sidst redigeret af
                                  #44

                                  Deres PharmaShell teknologi kunne være godt bud på Long acting injectables for en række lægemidler. Har projekt med liraglutid. Desuden muligt partnerskab med Novo Nordisk, mon ikke glp1/sema, men undisclosed Her ligger upside især og Novo skal snart beslutte, om de vil indgå licensaftale. Lav marketcap., høj
                                  risiko, stor upside.

                                  1 Reply Last reply
                                  0
                                  • D Offline
                                    D Offline
                                    DECIDE
                                    wrote on sidst redigeret af
                                    #45

                                    Xspray en en anden jeg har øje til. Dasynoc har PDUFA dato 31. juli i år. Høj
                                    risiko også, men kan blive stort.

                                    1 Reply Last reply
                                    0
                                    • D Offline
                                      D Offline
                                      DECIDE
                                      wrote on sidst redigeret af
                                      #46

                                      Som en sidste vil jeg nævne BioInvent. Har efterhånden 5 molekyler i klinikken, og der venter et meget spændende år med mange data, særlig på
                                      BI1808 og BI1206.

                                      1 Reply Last reply
                                      0
                                      • D Offline
                                        D Offline
                                        DECIDE
                                        wrote on sidst redigeret af
                                        #47

                                        Hører gerne fra andre om de tre selskaber og jeres vurdering.

                                        1 Reply Last reply
                                        0
                                        • exitnuE Offline
                                          exitnuE Offline
                                          exitnu
                                          wrote on sidst redigeret af
                                          #48

                                          Calliditas Therapeutics - Calliditas Q1 report, January – March 2024:

                                          Link Preview Image
                                          Calliditas Therapeutics AB

                                          Calliditas is a commercial stage biopharmaceutical company focused on identifying, developing and commercializing novel treatments in orphan indications, with an initial focus on renal and hepatic diseases with significant unmet medical needs.

                                          favicon

                                          Calliditas Therapeutics AB (www.calliditas.se)

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind
                                          Svar
                                          • Svar som emne
                                          Login for at svare
                                          • Ældste til nyeste
                                          • Nyeste til ældste
                                          • Most Votes


                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          Powered by NodeBB Contributors
                                          • First post
                                            Last post
                                          0
                                          • Kategorier
                                          • Seneste
                                          • Etiketter
                                          • Populære
                                          • Verden
                                          • Bruger
                                          • Grupper